This announcement is a separate document:
中國抗體-B:建議採納二零二二年購股權計劃及股東特別大會通告
SINOMAB BIO-B: PROPOSAL FOR ADOPTION OF THE 2022 SHARE OPTION SCHEME AND NOTICE OF EXTRAORDINARY GENERAL MEETING
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.